TPC1通过mTORC1和TFEBEB调节黑色素瘤瘤的发生
Xuhui Jin1, Ali A Hanbashi1,2, Faroq Kamli1,2
1Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, United Kingdom.
Heliyon
|November 11, 2024
概括
通过淘汰TPC1,一个内体阴离子通道,通过降低mTORC1活性来抑制黑色素瘤的进展. 这导致侵袭性降低和色素增加,突出显示TPC1是黑色素瘤的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 转移性传播和耐治疗性是癌症死亡率的主要原因.
- 由癌细胞与微环境相互作用所驱动的内现象型异质性,推动了疾病的进展.
- 拉帕米辛复合物1 (mTORC1) 活动的机械标对于转移性生长和向治疗耐药性至关重要.
研究的目的:
- 为了研究TPC1的作用,一个内体阴离子通道,在黑色素瘤的进展.
- 为了阐明下游信号通路受影响的TPC1淘汰在黑色素瘤细胞.
- 确定TPC1作为潜在的治疗点,用于治疗黑色素瘤.
主要方法:
- 在实验研究中利用了小鼠B16-F0黑色素瘤细胞系.
- 生成的TPC1淘汰赛 (KO) 黑色素瘤细胞.
- 评估mTORC1活动,细胞增殖,侵入性,色素和转录因子TFEB局部化.
主要成果:
- TPC1淘汰赛显著降低了黑色素瘤细胞中的mTORC1活性.
- TPC1 KO黑色素瘤细胞表现出减少的增殖和侵入性.
- 在TPC1 KO黑色素瘤细胞中观察到TFEB的增加色素和核定位.
结论:
- 在黑色素瘤中,TPC1淘汰会诱导显著的瘤抑制作用.
- 改变mTORC1活动和TFEB调节是TPC1抑制瘤作用的关键机制.
- TPC1是黑色素瘤进展的关键调节者,也是潜在的治疗点.
更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
6.7K
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
12.8K
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
